ioxilan has been researched along with Diabetes Mellitus in 1 studies
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sodium bicarbonate has been suggested as a possible strategy for prevention of contrast medium-induced nephropathy, a common cause of renal failure associated with prolonged hospitalization, increased health care costs, and substantial morbidity and mortality." | 2.73 | Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. ( Aharonian, VJ; Brar, SS; Burchette, RJ; Desai, N; Jorgensen, MB; Kotlewski, A; Ree, M; Shah, AI; Shen, AY, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brar, SS | 1 |
| Shen, AY | 1 |
| Jorgensen, MB | 1 |
| Kotlewski, A | 1 |
| Aharonian, VJ | 1 |
| Desai, N | 1 |
| Ree, M | 1 |
| Shah, AI | 1 |
| Burchette, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate[NCT00312117] | Phase 3 | 300 participants | Interventional | 2006-01-31 | Completed | ||
| Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill : A Multiple Center Randomized Clinical Trial (BICAR-ICU)[NCT02476253] | Phase 3 | 400 participants (Anticipated) | Interventional | 2015-05-05 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ioxilan and Diabetes Mellitus